Literature DB >> 19116612

Inhibiting microRNA function in vivo.

Pedro P Medina, Frank J Slack.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19116612     DOI： 10.1038/nmeth0109-37

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  10 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.

Authors:  Margaret S Ebert; Joel R Neilson; Phillip A Sharp
Journal:  Nat Methods       Date:  2007-08-12       Impact factor: 28.547

3.  Stable knockdown of microRNA in vivo by lentiviral vectors.

Authors:  Bernhard Gentner; Giulia Schira; Alice Giustacchini; Mario Amendola; Brian D Brown; Maurilio Ponzoni; Luigi Naldini
Journal:  Nat Methods       Date:  2008-11-30       Impact factor: 28.547

4.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

5.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

Authors:  Yoji Hayashita; Hirotaka Osada; Yoshio Tatematsu; Hideki Yamada; Kiyoshi Yanagisawa; Shuta Tomida; Yasushi Yatabe; Katsunobu Kawahara; Yoshitaka Sekido; Takashi Takahashi
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

6.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223.

Authors:  Jonathan B Johnnidis; Marian H Harris; Robert T Wheeler; Sandra Stehling-Sun; Michael H Lam; Oktay Kirak; Thijn R Brummelkamp; Mark D Fleming; Fernando D Camargo
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

Review 7.  miRiad roles for the miR-17-92 cluster in development and disease.

Authors:  Joshua T Mendell
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

8.  The let-7 microRNA represses cell proliferation pathways in human cells.

Authors:  Charles D Johnson; Aurora Esquela-Kerscher; Giovanni Stefani; Mike Byrom; Kevin Kelnar; Dmitriy Ovcharenko; Mike Wilson; Xiaowei Wang; Jeffrey Shelton; Jaclyn Shingara; Lena Chin; David Brown; Frank J Slack
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

Review 9.  microRNAs and cancer: an overview.

Authors:  Pedro P Medina; Frank J Slack
Journal:  Cell Cycle       Date:  2008-08-17       Impact factor: 4.534

10.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.

Authors:  Michaela Scherr; Letizia Venturini; Karin Battmer; Michael Schaller-Schoenitz; Daniel Schaefer; Iris Dallmann; Arnold Ganser; Matthias Eder
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971
  10 in total
  16 in total

Review 1.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

Review 2.  Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.

Authors:  Leonardo Fonseca Rodrigues; Vivaldo Moura-Neto; Tania Cristina Leite de Sampaio E Spohr
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

3.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Maria Nascimento Primo; Camilla Darum Sørensen; Jacob Giehm Mikkelsen
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

4.  Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.

Authors:  Anne Kruse Hollensen; Rasmus O Bak; Didde Haslund; Jacob Giehm Mikkelsen
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

5.  High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

Authors:  Yiming Zhou; Lijuan Chen; Bart Barlogie; Owen Stephens; Xiaosong Wu; David R Williams; Marie-Astrid Cartron; Frits van Rhee; Bijay Nair; Sarah Waheed; Mauricio Pineda-Roman; Yazan Alsayed; Elias Anaissie; John D Shaughnessy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 6.  MicroRNA in central nervous system trauma and degenerative disorders.

Authors:  Nai-Kui Liu; Xiao-Ming Xu
Journal:  Physiol Genomics       Date:  2011-03-08       Impact factor: 3.107

7.  Altered microRNA expression following traumatic spinal cord injury.

Authors:  Nai-Kui Liu; Xiao-Fei Wang; Qing-Bo Lu; Xiao-Ming Xu
Journal:  Exp Neurol       Date:  2009-07-01       Impact factor: 5.330

8.  On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210.

Authors:  Haissi Cui; Sebastien Grosso; Florian Schelter; Bernard Mari; Achim Krüger
Journal:  Front Pharmacol       Date:  2012-07-12       Impact factor: 5.810

9.  MicroRNAs as Novel Biomarkers for Breast Cancer.

Authors:  H M Heneghan; N Miller; A J Lowery; K J Sweeney; M J Kerin
Journal:  J Oncol       Date:  2009-07-20       Impact factor: 4.375

10.  The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor.

Authors:  Li Zhang; Lian-Yan Dong; Ya-Jian Li; Zhen Hong; Wen-Shi Wei
Journal:  J Neuroinflammation       Date:  2012-09-06       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.